Merck's Case Ethical

Merck's case study fact Facts: Merck is one of the world's largest pharmaceutical companies. Merck is to lose the patent protection of the two best-selling drugs, which accounts for the majority of the annual turnover of $ 2 billion. Merck invested millions of dollars in research (up to $ 1 billion) and within three years Merck discovered four powerful medicines. Merck does not care about profits; the founder of Merck believes as follows.

I will detail the three ethical theories and analyze Merck's case based on each theory and summarize how the authors and supporters of each theory position it in this case. The three theories used in case studies are John Stuart Mill's Utilitarian ethical theory, Immanuel Kant's moral theory's best subject, and Voice of Care for Kant and Mills. Contemporary Challenges of Mainstream Ethics Merck researchers have discovered ways to treat river dysfunction caused by parasites and carried by fly. And it had a negative effect on many people in the third world countries. After testing drugs to improve safety through clinical trials, the company tried to sell drugs through information sources like the World Health Organization and several US health agencies.

Merck known as Merck Sharp & Dohme outside the United States and Canada did not address the safety issues of EMA. However, clinical trials are in compliance with "laws, regulations, guidelines", and it happens no matter where it occurs only after approval by regulatory bodies and ethics committees. The company also emphasized: "A new medical history is collected every study visit, it is essential for all subjects, a new medical history also includes collection of non-serious adverse events." E - mail tells the inspector that inspection data is available. The company succeeded in attracting institutions with previously approved discussions. "The applicant found that collecting new historical data is essential for all subjects and does not seem to be passively collected, but found to be relieved at each study visit," EMA said.